Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials (Q42292313)

From Wikidata
Jump to navigation Jump to search
scientific article published on 2 March 2017
edit
Language Label Description Also known as
English
Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials
scientific article published on 2 March 2017

    Statements

    Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials (English)
    1 reference
    Richard J Gralla
    1 reference
    Fatima Ahmad
    1 reference
    Jaime D Blais
    1 reference
    Joseph Chiodo
    1 reference
    Wen Zhou
    1 reference
    Linda A Glaser
    1 reference
    Frank S Czerwiec
    1 reference
    2 March 2017
    1 reference
    723-729
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit